BARBANTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 11.186
AS - Asia 10.675
EU - Europa 8.403
SA - Sud America 1.574
AF - Africa 87
OC - Oceania 11
Totale 31.936
Nazione #
US - Stati Uniti d'America 11.053
HK - Hong Kong 7.856
IE - Irlanda 5.956
SG - Singapore 1.903
BR - Brasile 1.345
GB - Regno Unito 913
CH - Svizzera 406
FI - Finlandia 325
VN - Vietnam 325
IT - Italia 251
DE - Germania 210
TR - Turchia 132
CN - Cina 109
AR - Argentina 90
CA - Canada 63
FR - Francia 60
BD - Bangladesh 58
IN - India 55
MX - Messico 49
EC - Ecuador 46
EE - Estonia 40
NL - Olanda 38
CZ - Repubblica Ceca 36
RU - Federazione Russa 33
ID - Indonesia 32
PL - Polonia 29
ZA - Sudafrica 29
CO - Colombia 27
KR - Corea 25
UZ - Uzbekistan 24
IQ - Iraq 23
JP - Giappone 21
PK - Pakistan 19
PY - Paraguay 18
SE - Svezia 18
UA - Ucraina 17
AT - Austria 16
ES - Italia 15
CL - Cile 14
EG - Egitto 13
MA - Marocco 13
UY - Uruguay 13
KE - Kenya 12
VE - Venezuela 12
IR - Iran 11
AU - Australia 9
IL - Israele 9
PE - Perù 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
BG - Bulgaria 6
LT - Lituania 6
NP - Nepal 6
SA - Arabia Saudita 6
PH - Filippine 5
TN - Tunisia 5
AZ - Azerbaigian 4
BE - Belgio 4
ET - Etiopia 4
KG - Kirghizistan 4
LV - Lettonia 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
JM - Giamaica 3
KZ - Kazakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
LY - Libia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 31.927
Città #
Hong Kong 7.855
Dallas 6.292
Dublin 5.918
Singapore 912
Ashburn 865
London 833
Boardman 807
Santa Clara 434
Zurich 406
Helsinki 313
The Dalles 274
Washington 197
Ho Chi Minh City 117
São Paulo 115
Istanbul 110
Los Angeles 107
Assago 76
Hanoi 74
Munich 72
Rio de Janeiro 46
San Francisco 42
Chicago 41
New York 38
Belo Horizonte 36
Montreal 28
Council Bluffs 27
Frankfurt am Main 27
Milan 27
Brasília 26
Brooklyn 26
Seattle 26
Seoul 25
Warsaw 23
Brno 21
Tashkent 21
Porto Alegre 20
Amsterdam 19
Guayaquil 19
Salvador 18
Stockholm 18
Johannesburg 17
Atlanta 16
Boston 16
Curitiba 16
Mexico City 16
Quito 15
Catania 14
Olomouc 14
Shanghai 14
Tokyo 14
Campinas 13
Haiphong 13
Chennai 12
Da Nang 12
Falkenstein 12
Guarulhos 12
Montevideo 12
Rome 12
Buenos Aires 11
Dhaka 11
Duque de Caxias 11
Goiânia 11
Nairobi 11
Cipolletti 10
Hải Dương 10
Thái Bình 10
Turku 10
Bexley 9
Clifton 9
Düsseldorf 9
Fortaleza 9
Manchester 9
Phoenix 9
Piscataway 9
Guangzhou 8
Joinville 8
Manaus 8
Osasco 8
Ribeirão Preto 8
Tanta 8
Tappahannock 8
Amman 7
Columbus 7
Denver 7
Genoa 7
Jakarta 7
Karachi 7
Maceió 7
Mumbai 7
Ottawa 7
Santo André 7
Sumaré 7
São José dos Campos 7
Thái Nguyên 7
Toronto 7
Ankara 6
Araraquara 6
Bauru 6
Biên Hòa 6
Bogotá 6
Totale 26.943
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.445
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.165
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 958
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 954
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 711
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 641
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 554
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 534
Predicting neocommissural orientation during TAVI workup 504
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 487
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 426
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 374
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 372
Le nuove frontiere della cardiologia interventistica strutturale 350
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 136
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 129
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 123
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 122
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 119
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 118
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 118
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 112
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 111
Transcatheter mitral valve implantation: CardiAQ 110
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 110
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 110
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 101
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 99
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 97
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 97
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 97
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 97
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 96
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 96
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 95
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 94
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 94
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 93
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 93
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 93
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 92
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 89
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 87
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 86
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 85
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 85
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 85
Managing complications after transcatheter aortic valve implantation 82
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 82
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 81
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 81
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 81
Early detection of transcatheter heart valve dysfunction 80
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 80
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 79
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 79
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 78
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 77
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 77
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 77
The Helio transcatheter aortic dock for patients with aortic regurgitation 76
Cerebral embolization during transcatheter aortic valve implantation 76
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 76
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 76
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 76
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 76
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 75
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 75
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 75
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 74
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 73
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 73
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 73
Management of severe stenosis controversies and promises 73
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 73
Bioprosthetic valves for transcatheter aortic valve replacement 72
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 72
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 71
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 71
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 71
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 71
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 70
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 70
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 70
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 69
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 69
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 69
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 69
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 69
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 69
Transcatheter mitral valve repair: a brief review 68
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 68
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 68
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 68
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 68
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 68
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 68
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 68
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 68
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 68
Totale 17.730
Categoria #
all - tutte 146.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/20269.158 870 3.391 3.663 1.212 22 0 0 0 0 0 0 0
Totale 32.383